Latest Breaking News On - News ratings for ligand pharmaceuticals daily - Page 2 : comparemela.com

Insider Selling: Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Insider Sells 3,440 Shares of Stock

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) insider Matthew E. Korenberg sold 3,440 shares of Ligand Pharmaceuticals stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $84.54, for a total value of $290,817.60. Following the sale, the insider now directly owns 100,421 shares in […]

Matthewe korenbergScarborough advisorsInstitutional investors weigh in on ligand pharmaceuticalsSecurities exchange commissionPrincipal securities incChina universal asset management coLigand pharmaceuticals price performanceFinancial services group incMr capital management incLigand pharmaceuticalsLigand pharmaceuticals incorporatedNews ratings for ligand pharmaceuticals dailyLigand pharmaceuticals company profileGet free reportExchange commissionPharmaceuticals incorporated

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Insider Matthew E. Korenberg Sells 3,440 Shares of Stock

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) insider Matthew E. Korenberg sold 3,440 shares of the company’s stock in a transaction dated Monday, May 13th. The shares were sold at an average price of $84.54, for a total transaction of $290,817.60. Following the sale, the insider now directly owns 100,421 shares of the company’s […]

United statesMatthewe korenbergVictory capital management incCapula management ltdLigand pharmaceuticals stockChina universal asset management coNews ratings for ligand pharmaceuticals dailyLigand pharmaceuticals incorporatedLigand pharmaceuticalsInstitutional trading of ligand pharmaceuticalsGet free reportPharmaceuticals incorporatedUniversal asset managementRetirement systemManagement ltdVictory capital management

Ligand Pharmaceuticals (NASDAQ:LGND) Releases Earnings Results, Beats Expectations By $3.01 EPS

Ligand Pharmaceuticals (NASDAQ:LGND) Releases Earnings Results, Beats Expectations By $3.01 EPS
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

Stephenl sabbaEarnings history for ligand pharmaceuticalsNews ratings for ligand pharmaceuticals dailyLigand pharmaceuticals tradingLigand pharmaceuticals incorporatedSecurities exchange commissionLigand pharmaceuticalsLigand pharmaceuticals company profileGet free reportDirector stephenExchange commissionPharmaceuticals incorporatedLigand pharmaceuticals daily

HC Wainwright Reaffirms Buy Rating for Ligand Pharmaceuticals (NASDAQ:LGND)

HC Wainwright Reaffirms Buy Rating for Ligand Pharmaceuticals (NASDAQ:LGND)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Stephenl sabbaLigand pharmaceuticals incorporatedNews ratings for ligand pharmaceuticals dailyLigand pharmaceuticals tradingLigand pharmaceuticalsPacer advisors incChina universal asset management coDeutsche bankAllspring global investments holdingsImpax asset management groupGet free reportDirector stephenAsset management groupGlobal investments holdingsUniversal asset managementPharmaceuticals incorporated

Ligand Pharmaceuticals (NASDAQ:LGND) Posts Earnings Results, Beats Estimates By $3.01 EPS

Ligand Pharmaceuticals (NASDAQ:LGND) Posts Earnings Results, Beats Estimates By $3.01 EPS
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

Stephenl sabbaLigand pharmaceuticals company profileLigand pharmaceuticals stockLigand pharmaceuticals incorporatedNews ratings for ligand pharmaceuticals dailyLigand pharmaceuticalsEarnings history for ligand pharmaceuticalsGet free reportDirector stephenPharmaceuticals incorporatedLigand pharmaceuticals daily